FIELD: pharmacology.
SUBSTANCE: group of inventions is a pharmaceutical composition for use in treatment of Parkinson's disease comprising a pharmaceutically acceptable carrier and a combination of fixed-dose pramipexole and rasagiline; and a method for production of a sustained release formulation comprising a combination of pramipexole and rasagiline or a pharmaceutically acceptable salt thereof with fixed doses thereof. This combination with fixed doses contains 0.05 to 1.0 mg of pramipexole and 0.055 to 1.0 mg of rasagiline.
EFFECT: group of invention allows to reduce the amount of side effects while maintaining high efficiency of the pharmaceutical composition by reducing the dose of pramipexole and maintaining a high dose of rasagiline.
19 cl, 4 dwg, 6 tbl, 4 ex
